Does Rhonda Patrick recommend Ashwagandha?
Rhonda Patrick recommends Ashwagandha in some contexts, but has also raised cautions.
Published research rates it moderate evidence. Of Rhonda Patrick's 240 tracked claims, 99 are supported or partially supported by studies on PubMed.
Evidence last reviewed May 2026
Rhonda Patrick on Ashwagandha — 240 claims
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim references a specific 2012 study by Chandrasekhar et al. examining serum cortisol reduction with ashwagandha. None of the 10 studies provided in the research list correspond to this…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The published research list includes multiple RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and clinical guidelines (PMID 35311615) that are directly relevant to ashwagan…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided research abstracts contain no key findings, population details, or limitations data that directly address which ashwagandha extracts are most commonly studied in clinical trials. While th…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided literature includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with the general scientific conver…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is the 'most clinically studied adaptogen' is a comparative assertion requiring head-to-head bibliometric data across all adaptogens (e.g., Rhodiola rosea, Panax ginseng, El…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The available literature includes a meta-analysis (PMID: 36017529) and at least one RCT (PMID: 31517876) that are directly relevant to ashwagandha's effects on stress and anxiety, and the general dire…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the Chandrasekhar et al. 2012 RCT and cites a precise 27% reduction in serum cortisol with ashwagandha. While that study is a well-known published RCT, it do…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The available evidence base includes a meta-analysis (PMID: 36017529), multiple RCTs (PMIDs: 31517876, 37740662, 35984870), and a WFSBP/CANMAT clinical guideline (PMID: 35311615), all of which are rel…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The available literature includes a meta-analysis (PMID 36017529, rated strong quality) and multiple RCTs (PMIDs 31517876, 37740662, 35984870) that appear directly relevant to ashwagandha's effects on…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in the provided list and would be expected to address ashwagandha's effects on testosterone in men,…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion requiring head-to-head data on clinical trial volume across multiple adaptogens (e.g., Panax ginseng, R…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The published research includes multiple RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and WFSBP/CANMAT clinical guidelines (PMID 35311615) that are consistent with ashwa…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert specifically cites a 2012 Chandrasekhar et al. study with a ~27% cortisol reduction, but that study does not appear by name or PMID in the provided research list. While the list includes se…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and at least one double-blind RCT (PMID: 31517876) that appear to examine ashwagandha's effects on anxiety and…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The provided research corpus does not contain the specific RCTs examining ashwagandha's effect on testosterone in infertile or sub-fertile men that would be needed to directly evaluate Patrick's claim…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided research abstracts contain no extractable key findings, populations, or limitations — the metadata fields are uniformly empty — making it impossible to directly verify or contradict the c…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The available research list includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with investigating cortisol an…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion requiring head-to-head evidence against other adaptogens (e.g., Rhodiola rosea, Panax ginseng, Eleuther…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert references the Chandrasekhar et al. 2012 RCT specifically, claiming approximately 27% reduction in serum cortisol with ashwagandha. However, that specific study does not appear in the provi…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The available research corpus includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with the general claim that…
Other supplements Rhonda Patrick discusses
Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only — consult a healthcare provider before starting any supplement.
Back to Rhonda Patrick